Assuming that Lympro becomes the only accurate test out there to safely and quickly identify the onset of ALZ before symptoms appear, I'd go out on a limb and start the bidding at $500,000,000. As I stated before, why would a BP want to share this test with competitors when they can have it all to themselves?